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1. Introduction 
1.1 Distraction osteogenesis 
Bone is amongst the very few tissues in the human body that possess intrinsic capacity to heal 
spontaneously following injury. However, beyond a certain critical size defect, bone cannot 
heal by itself and outside intervention is required. Numerous techniques are available for the 
management of these defects, including the gold standard autogenous bone grafts, allografts, 
bone graft substitutes, vascularized fibular bone grafts and systemic administration of anabolic 
agents. All these techniques, however, do have limitations (Dimitriou et al., 2011; Nauth et al., 
2011). Such instances of severe bone loss, whether due to congenital bony deficiencies or 
acquired causes, pose an immense challenge to the treating physicians, and it is in these cases 
that distraction osteogenesis could offer a viable and successful alternative to these techniques. 
Distraction osteogenesis (DO) is a surgical technique in which the intrinsic capacity of bone to 
regenerate is being harnessed to lengthen bones or to replace large segments of bone. It 
consists of the application of an external fixator to the affected bone (Figure 1), followed by an 
osteotomy of the bone and then gradual and controlled distraction is applied to the two bone 
segments. This controlled distraction, usually by an external fixator, generates new bone 
within the distracted gap. When the desired lengthening is obtained, distraction is stopped 
and the external fixator is kept on until the newly formed in the distracted gap is mechanically 
strong enough to allow removal of the fixator. DO is considered a type of in vivo bone tissue 
engineering and is superior to other methods of bone regeneration in the management of cases 
of bone loss, because this technique allows the spontaneous formation of de novo native bone 
without the need for bone grafts. DO also has the unique ability to regenerate bone and soft 
tissues simultaneously.  
2. Historical aspect of distraction osteogenesis  
Codivilla from Italy is credited for having performed the first lengthening procedure by 
applying skeletal traction through a calcaneal pin, following osteotomy of the femur 
(Codivilla, 1905 ). However, it was a Russian surgeon,  Gavriil Ilizarov, who pioneered the 
biological principles of bone and soft tissue regeneration and popularized the technique of 
distraction osteogenesis, when he discovered that under slow and gradual distraction, new 
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bone will regenerate in the distracted gap (Ilizarov, 1989a; Ilizarov, 1989b). Starting in the early 
1950s, he worked in a village in Siberia, Kurgan, unknown to the rest of the world. Then, in 
1982, he successfully treated a famous Italian explorer “Carlo Mauri” for a resistant non-union 
of his tibia and it was only then when his principles were made known to the Western World.  
3. Ilizarov principles or the law of tension stress (Green, 2011)  
Ilizarov developed the law of tension-stress, which describes the process of new bone and soft 
tissue regeneration under the effect of tension-stress caused by slow and gradual distraction. 
His biological principles can be summarized as follows: 
3.1 Minimal disturbance of bone and soft tissues 
Ilizarov showed that formation of new bone at the osteotomy site is definitely influenced by 
the amount of damage to the bone, medullary cavity, and periosteum. He described the new 
concept of corticotomy, where only the cortex of the bone is cut, preserving the periosteum 
and medullary cavity. The value of corticotomy has recently been questioned, because the 
medullary blood supply regenerates in 7 to 10 days following a complete osteotomy. The 
integrity of the periosteum is the only important factor for new bone formation at the site of 
the osteotomy.  
3.2 Delay before distraction 
(Latency phase) Duration of delay varies from 5 days in a child to about 10 days in a 
skeletally-mature patient. This allows the formation and organization of a hematoma.  
3.3 Rate and rhythm of distraction 
The optimum rate was found by Ilizarov to be 1mm/day and the optimum rhythm of 
distraction was 0.25mm every 6 hours. Elongation of more than 2mm/day may lead to 
slowing of osteogenesis, while elongation of 0.5mm/day or less may lead to premature 
consolidation. An autodistractor causing a continuous gradual and slow distraction of 1.0 
mm/day was found to be superior to a rhythm of four times a day. 
3.4 Site of lengthening 
Metaphyseal lengthening leads to better osteogenesis than diaphyseal lengthening. The 
metaphyseal region contains much more cancellous bone than the diaphyseal region and 
this type of bone has a much higher potential for osteogenesis. 
3.5 Stable fixation of the external fixator 
Similar to fracture healing, this has been shown to be of paramount importance. Some axial 
micromotion is, however, beneficial to the consolidation of the regenerate bone.  
3.6 Functional use of the limb and intense physiotherapy 
During the whole lengthening procedure, this is of foremost importance in order to obtain a 
satisfactory outcome.  
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4. Phases of distraction osteogenesis 
As shown in Figure 1, DO consists of the following phases: 
- Latency phase: This is the phase immediately following the osteotomy, where there is 
no distraction. It lasts 5 to 10 days 
- Distraction phase: the two bone segments are gradually distracted at a rate of 1.0 mm 
day in several increments, until the desired amount of lengthening is obtained.  
- Consolidation phase: distraction is ceased and the two bone segments are held in place 
until the newly formed bone in the distracted gap consolidates (about one month per 
cm lengthened) 
- Removal of the fixator.  
 
 
 
 
Fig. 1. Steps of the technique of distraction osteogenesis used for limb lengthening;  
A. Shows the bone to be lengthened; B. Application of the external fixator; C. Osteotomy of 
the proximal tibia; D. Start of distraction and E. End of distraction when desired amount of 
lengthening is obtained. 
5. Clinical significance of distraction osteogenesis 
DO is a very successful technique of bone regeneration, widely used for lengthening bones 
and in the management of bone loss secondary to congenital or acquired causes, both in 
long and tubular bones of the axial skeleton as well as flat bones of the craniofacial skeleton. 
It has many indications, including: 
5.1 Distraction osteogenesis as a bone lengthening technique 
DO could be used in restoring the length of bones in numerous conditions including 
congenital causes of bone defects specifically congenital limb deficiencies or acquired causes 
due to growth plate injuries leading to growth arrest and subsequent limb length 
discrepancy (Birch and Samchukov, 2004; Murray and Fitch, 1996), (Figure 2).  
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Fig. 2. Lengthening of short tibia showing various phases of the distraction process.  
A. Application of the fixator and osteotomy of the tibia; B. Start of distraction; C. End of 
distraction; D. and E. Consolidation phase, without any distraction, until bone in the 
distracted gap consolidates; F. Removal of the fixator. 
 
Fig. 3. Examples of short bones lengthened by distraction osteogenesis. A. A very short 
femur; B. Short 4th metatarsal bone pre and post lengthening; C. Amputation stump pre-
lengthening, D. During distraction phase, and E. Post-lengthening.  
5.2 Distraction osteogenesis as a bone transport technique 
DO is also widely used for the reconstruction of large segmental skeletal defects by a special 
technique called bone transport (Figure 4). The magnitude of this problem is enormous. 
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Approximately 150,000 segmental skeletal defects are sustained in the United States each 
year as a result of trauma (Cierny and Zorn, 1994). To this must be added a significant 
number of bone defects following debridement after severe cases of osteomyelitis (Cierny 
and DiPasquale, 2011) and resections for malignant bone tumours (Tsuchiya, 2011).  
 
 
 
Fig. 4. A and B. Showing the segmental bone defect; C. Application of the external fixator, 
the bone defect and osteotomy of the proximal tibia; D. Start of distraction and transport of 
the healthy bone segment distally to fill the bone defect, while at the same time, new 
regenerate bone is formed in the distracted gap proximally; E. Completion of the bone 
transport.  
 
 
 
Fig. 5. A. Showing large segmental bone loss of the tibia due to severe trauma; B. Application 
of the external fixator; C. Completion of the bone transport and successful and successful bone 
formation in the distracted zone; D. Complete bone regeneration of the affected bone. 
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5.3 Distraction osteogenesis in the craniofacial skeleton 
The clinical use of DO is not only limited to orthopaedic problems, but extends to the field 
of cranio-facial surgery. Mandibular distraction was first performed in 1973 in a canine 
model (Snyder et al., 1973). However, it was only in 1992 when it was first reported in 
humans (Mccarthy et al., 1992). Currently, both extraoral and intraoral devices may be 
used depending on the condition to be treated (Goldwaser et al., 2011). Commonly treated 
conditions include craniofacial deficiencies, syndromic craniosynostosis, Pierre Robin 
Sequence, posttraumatic deformities, and sleep-related breathing disorders (Vander Kolk 
et al., 2001). 
6. Types of external fixators used in distraction osteogenesis for long bones  
There are two types of external fixators used in DO: circular and monolateral. Circular 
fixators, also called ring fixators, include the standard circular frames (Figure 6A) described 
by Ilizarov and the more recent Taylor Spatial Frames (Feldman and Chaudhry, 2011). 
Monolateral fixators consist of a single bar transfixing bone with screws and pins (Figure 
6B). Hybrid fixators also have been developed, consisting of a combination of circular and 
monolateral constructs.  
 
 
 
Fig. 6. A. (Circular); B. (Monolateral) External fixators. 
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7. Cellular events in distraction osteogenesis 
The histological features of DO closely resemble those of fracture healing, as shown in Figure 
7. Immediately after the osteotomy, a hematoma is formed. As distraction progresses, this 
hematoma is organized into fibrous and fibro-cartilaginous tissue in a longitudinal pattern 
along the direction of distraction and gives a striated appearance. New bone starts to be 
formed as early as two weeks after distraction. This new bone is formed from the periosteum, 
from the cortex at the site of the osteotomy and from the spongiosa and proceeds from the 
osteotomy cuts towards the center, always forming a fibrous, radiolucent interzone between 
the two advancing edges of the mineralization front (Aronson et al., 1990; Aronson et al., 1989; 
Aronson et al., 1997; Hamdy et al., 1997). Besides the formation of new bone in the distracted 
gap, all the surrounding soft tissues are also stimulated and lengthened, including skin, 
muscles, connective tissue, nerves and vessels (Makarov et al., 2009).  
8. Molecular events and mechanism of bone formation in distraction 
osteogenesis  
New bone formation in DO occurs through mechanotransduction, the process by which the 
mechanical tension-stress forces induced by distracting the bony segments at the site of the 
osteotomy, are converted into a cascade of molecular signals, which in turn activate 
numerous cellular events (differentiation, proliferation and secretory functions), that 
ultimately lead to new bone formation (Huang and Ogawa, 2010). We and others (Ai-Aql et 
al., 2008; Haque et al., 2007; Haque et al., 2008; Haque et al., 2006; Rauch et al., 2000) have 
shown that the mechanical forces applied during DO lead to the temporal and spatial 
expression of numerous cytokines, growth factors including BMP (Bone Morphogenetic 
Proteins), FGF (Fibroblast Growth Factor), IGF (Insulin Growth Factor), TGFB 
(Transforming Growth Factor B), PDGF (Platelet Derived Growth Factor), vascular factors 
VEGF (Vascular Endothelial Growth Factor),  HIF (Hypoxia Induced Factor),  as well as 
extracellular matrix proteins (Sato et al., 1998) and matrix metalloproteinases (Marucci et al., 
2002). During the distraction phase, while the distraction forces are still being applied, many 
of these molecules are up-regulated and then, once the distraction forces cease at the end of 
the distraction phase, they become down-regulated.  
9. The role of angiogenesis in distraction osteogenesis  
DO is a vascular dependent process and new bone formation in DO is associated with 
robust neo-angiogenesis and neo-vascularity (Choi et al., 2000; Choi et al., 2002). There is an 
increased expression of numerous vascular growth factors in the distracted zone, including 
VEGF, HIF, basic FGF and Angiopoietin (Pacicca et al., 2003). Mobilization of endothelial 
progenitor cells have been described to play a major role in new bone formation in DO (Lee 
et al., 2008).  
1. Haematoma formation after osteotomy and start of distraction 
2. Mid-distraction showing start of bone formation 
3. End of distraction (2.0 cms) showing fibrous interzone in the middle of the distracted 
zone. New bone formation is laid down longitudinally along the direction of distraction 
stress 
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4-5. Fibrous interzone decreases as new bone formation advances from the osteotomy ends 
 towards the centre of the distracted zone 
6. New bone completely bridges the distraction gap. 
 
 
Co: Cortex, Mc: Medullary cavity, Ca: callus, FIZ: fibrous interzone. 
Fig. 7. Cellular changes during distraction osteogenesis of the tibia of 2.0 cms in a rabbit 
model of DO using modified uniplanar fixator (trichrome staining), Reprint with permission 
from Bone. 2000 Jun;26(6):611-7:  
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10. Types of bone formation in distraction osteogenesis  
While many aspects of DO, both at the cellular and molecular level have been elucidated, 
the exact mechanism and type of bone formation in DO is still being debated. Numerous 
authors have reported that regenerate bone formation in DO is mostly intramembranous 
(Aronson et al., 1990; Fink et al., 2003). However, others reported the presence of 
predominantly endochondral bone (Delloye et al., 1990; Kojimoto et al., 1988). Ilizarov 
believed that new bone formation in a canine model of DO, was mostly intramembranous, 
although he also described the presence of islands of cartilage-like cells (Ilizarov, 1989a; 
Ilizarov, 1989b). Our own results in several animal models of DO (dogs, rabbits and mice), 
revealed a combination of both types of ossification (Hamdy et al., 2003; Hamdy et al., 1997). 
Yasui et al (Yasui et al., 1997) in a rat model of DO, described a third type of ossification 
called transchondroid. It is also possible that the type of intra-membranous formation in DO 
is different from that of bone development, as reported by Isefuku et al (Isefuku et al., 2004), 
who showed that DO in Cbfa1 heterozygous knockout mice, new bone formation was the 
same as that of the controls. While the debate regarding the type of bone formation in DO 
will likely continue, many factors have been identified as playing a major role in 
determining which type of bone formation will predominate. These include stability of the 
fixator, vascularity of the surrounding tissues, rate and rhythm of distraction and the animal 
species in which DO was tested.  
 
Fig. 8. Histological sections at the middle of distracted zone of rabbits sacrificed at 5 weeks 
post surgery. Trichrome Goldner staining showing mineralized tissue (bone and cartilage) 
in green, unmineralized cartilage in orange red. Chondrocyte-like cartilage is seen in large 
amounts.  
11. Problems and issues associated with the technique of distraction 
osteogenesis and current research aimed at addressing these issues 
Although very popular and very successful worldwide as a method of bone regeneration, 
this technique has several problems, specifically the long period of time that the external 
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fixator needs to be kept on until the newly formed bone in the distracted zone consolidates. 
It has been shown by Ilizarov that the distraction phase cannot be increased, as this may 
lead to poor regenerate bone formation and soft tissue problems, such as contractures and 
neurovascular problems. The consolidation phase is long, requiring the fixator to be kept on 
about one month for every cm lengthened. For example, a lengthening of 6.0 cms, would 
require the fixator to be kept for about 6 months. This, in turn, can lead to or exacerbate 
many medical, psychological, social and financial problems for the patient and his family 
(Paley, 1990). These include pin site infections; pain that may require narcotic medications; 
edema of the lengthened limb causing discomfort and pain; psychological complications; 
missing school days for children or working days for adults; long and continuous follow-up 
in the form of regular outpatient visits, frequent radiological examinations and re-
adjustment of the frame. The question then arises: how to accelerate the consolidation of the 
regenerate bone, so that the external fixator could be removed at an earlier time?  
12. Attempts at accelerating distraction osteogenesis 
Numerous attempts at enhancing newly formed bone have been described and include the 
application of external biophysical stimuli (i.e. mechanical loading), and administration of 
biological agents, systemically or locally. Most of these studies have been performed in 
animal models of DO (Sabharwal, 2011). These include;  
12.1 Mechanical loading, axial compression and dynamization  
The effect of mechanical loading on the maintenance of bone mass has long been 
recognized. The mechanical stresses induced in the soft tissues during distraction are 
converted into a cascade of signals (mechanotransduction) that lead to the activation of 
numerous osteogenic pathways. At the cellular level, there is cellular differentiation, 
angiogenesis formation, mineralization of bone matrix as well of bone remodeling. There are 
no strict guidelines as to the amount of compression or shortening necessary to enhance 
bone regeneration, however many authors recommend compression of three to five days 
after completing the lengthening. Some authors also recommended over lengthening by 
about 5mm followed by compression of 5mm (Hwang et al., 2009; Mori et al., 2006). 
12.2 Accordion maneuver  
This technique consists of alternating cycles of compression and distraction. Numerous 
variations of this technique have been described: alternated cycles of compression and 
distraction the same day, and compression for a period of 1 or more weeks followed by 
distraction for the same duration (Claes et al., 2008).  
12.3 Vibrations  
Numerous studies have shown that application of low magnitude and high frequency 
mechanical stimuli may have a beneficial effect on bone formation. Vibration plates have 
been and are being used to enhance bone formation. However, there had been no studies in 
cases of distraction osteogenesis in humans (Hou et al., 2011).  
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12.4 Ultrasound 
Numerous studies have shown the efficiency of LIPUS (Low Intensity Pulsed Ultrasound). 
The device is applied to the skin previously covered by gel corresponding to the point of 
fracture or distraction osteogenesis for 20 minutes a day. The treatment is usually self 
administered by the patient at home and the period of treatment ranges from 2 to 6 months 
or more, until healing is completed. Ultrasound may also enhance angiogenesis and increase 
the blood flow around the site of new bone formation (Busse et al., 2009; Claes and Willie, 
2007; Romano et al., 2009; Watanabe et al., 2010).  
12.5 Extra corporal Shock Wave (ESW)  
Positive effects of ESW on regenerate bone formation have been reported in rat mandibular 
and rabbit tibia models of DO (Lai et al., 2010; Narasaki et al., 2003).  
12.6 Electrical stimulation 
Electrical stimulation could be applied using capacitively coupled electric field (CCEF) 
method, direct current (DC) stimulation, electromagnetic stimulation or alternating current 
(AC) stimulation and has been shown to give positive results in animal studies (Hagiwara 
and Bell, 2000; Kawamoto et al., 2005; Pepper et al., 1996).  
12.7 Bisphosphonates 
As both, bone formation and bone resorption occur in distraction osteogenesis, it is 
reasonable to assume that blocking bone resorption by anti-resorptive agents, such as 
bisphosphonates, may lead to increased bone formation. Numerous animal studies have 
documented the positive effect of bisphosphonates in distraction process (Abbaspour et al., 
2009). In a case series of 7 patients, bisphosphonates were used for the treatment of poor 
regenerate bone (Kiely et al., 2007); six patients responded well and completely healed. 
However, despite the reported good results, there has been no other published series on the 
positive effect of bisphosphonates on enhancement of poor bone regeneration.  
12.8 Systemic drugs  
Other systemically administered drugs that have been investigated including, Calcitonin 
(Sen et al., 2006), Prostaglandin E2 (Yamane et al., 1999). 
12.9 Locally applied agents 
These include alpha-tocopherol (Kurklu et al., 2011); Adiponectin (Jiang et al., 2011); Inhibin A 
(Perrien et al., 2011); Nerve growth factor via a hydrogel (Cao et al., 2011); Thrombin peptide 508 
(Cakarer et al., 2010); Bone marrow progenitor cell mobilizing agent (Davidson et al., 2011); 
Calcium sulphate injection (Song et al., 2004); Osteoblast-like cells (Shao et al., 2007); Stromal cell 
derived factor-1 (Fujio et al., 2011); NEL-like molecule-1 (Xue et al., 2011).  
12.10 Cell therapy and platelet-rich plasma 
The use of bone marrow cells to enhance bone healing has been in use from many years. The 
problem with direct bone marrow injections is that the number of active osteogenic cells is 
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very low, and therefore special techniques have been developed to aspirate bone marrow, 
culture the cells in vitro so as to increase and expand their number and then inject them in 
the desired area of poor bone formation (fracture site, non-union, distracted zone). The use 
of platelet rich plasma alone was reported to give positive results in a human study (Latalski 
et al., 2011). The positive osteogenic effect of culture expanded bone marrow cells has also 
been reported when combined with platelet-rich plasma in humans and with bFGF in 
rabbits (Jiang et al., 2010; Kitoh et al., 2007). 
12.11 Combination of methods 
These include rhBMP-2 combined with HA-TCP biomaterial (Ni et al., 2011); BMPs and 
NEL-1 (Zhu et al., 2011); Autografts and demineralized bone matrix (Canter et al., 2007); 
autologous bone marrow demineralized bone matrix (Hatzokos et al., 2011). Another 
experimental study reported also on the positive effects of an internal drug releasing 
distractor where small doses of BMP-2 are released from chitosan gel with every distraction 
(Konas et al., 2009). 
12.12 Peptide growth factors  
These include TGF-β (Transforming Growth Factor Beta), IGF (Insulin Growth Factors) 
(Bernstein et al., 2010), FGFs (Fibroblast Growth Factors) (Okazaki et al., 1999), PDGF 
(Platelet Derived Growth Factor) (Moore et al., 2009), Hypoxia Induced Factor (Wan et al., 
2008). 
13. Bone Morphogenetic Proteins (BMPs) 
Of all the osteogenic growth factors, BMPs seem to be the most promising in stimulating 
bone formation in the context of DO. BMPs are members of the TGF-β superfamily acting on 
many systems including the kidney, heart and bone. These molecules are amongst the most 
powerful osteogenic growth factors and the only osteo-inductive ones that act on 
undifferentiated mesenchymal cells very early in the differentiation process (Gazzerro and 
Canalis, 2006; Miyazono et al., 2010; Rosen, 2006) (Figure 9).  
BMPs are produced by many cells, including osteoblasts, chondrocytes and platelets. BMP 
signaling is shown in Figure 14 and involves binding to specific membrane receptors, 
phosphorylation of Smads 1, 5 and 8 and binding with Co-Smad 4, translocation into the 
nucleus and activation of transcription factors. In bone, BMPs trigger a cascade of events 
leading to osteogenesis, chondrogenesis, angiogenesis and up-regulation of numerous 
growth factors and cytokines. Cross-talk between BMP, FGF and Wnt pathways has been 
reported. Numerous studies have shown that recombinant BMP2 and BMP7 stimulate new 
bone formation in critical size defects, long bone non-unions, fracture healing, spine fusion, 
and augmentation of autografts and allografts (Einhorn, 2003). 
13.1 Importance of BMPs in distraction osteogenesis 
There is enough evidence, today, to suggest that BMPs, specifically BMP2 and BMP7, do 
play a major role in regenerate bone formation in DO. First,  the expression of various 
members of the BMP signaling pathway was extensively analyzed, at the protein level using 
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immunohistochemistry and at the mRNA level using RT-PCR, and it was shown by us 
(Haque et al., 2007; Haque et al., 2008; Haque et al., 2006; Rauch et al., 2000) and others (Ai-
Aql et al., 2008) that BMP ligands, receptors, transcription factors and downstream targets 
are up-regulated during the distraction phase and then down-regulated once the mechanical 
forces of distraction cease.  
 
 
 
Fig. 9. BMPs acting on undifferentiated cells. 
Second, to confirm the important role of BMPs in DO in a mechanistic way, we studied the 
process of DO in conditional BMP2 knockout mice (supplied by Dr. V. Rosen, Boston) and 
found that there was a delay in bone formation in the distracted gap of the heterozygous 
mice (Figure 10), when compared to the control littermates, thus showing that BMP2 is 
essential for bone formation in DO (Haque et al., 2008) and also supporting the results of 
(Tsuji et al., 2006) who reported that BMP2 is required for the initiation of fracture healing.  
Third, we (Mandu-Hrit et al., 2006) and others (Lesaichot et al., 2011; Li et al., 2002; 
Mizumoto et al., 2003) have also reported that application of rhBMP7 and rhBMP2 in 
various animal models of DO, had a significant effect on the acceleration of bone formation 
in DO.  
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Fig. 10. Mini Ilizarov circular frame applied to a mouse model of DO in our laboratory , and 
developed by Tay et al. (Tay et al., 1998). 
However, the main problem with the use of BMPs in humans remains the large doses that 
have to be used in order to obtain clinical significant results.  
13.2 Issues associated with the use of large doses of BMPs in the clinic 
The rapid clearance of BMPs from the site of application when locally applied in the 
absence of an adequate system for sustained delivery and the short half life of BMPs 
mandate the use of large, supraphysiological doses of BMPs in the milligram range to 
achieve satisfactory bone healing (Haidar et al., 2009b; Haidar et al., 2010b). Importantly, 
the minimal effective dose of recombinant BMPs (rhBMP2 or rhBMP7) currently used is 
equivalent to the sum of all BMPs present in 1000 human skeletons! These expensive large 
supraphysiological doses could have numerous side effects and unknown serious long-
term effects as the expression of BMPs, including BMP2 and 7 is not exclusive to bones. 
BMPs have a neoplastic potential and although they have not been shown to directly 
cause malignancies, they are expressed in several tumors (Hsu et al., 2005). BMPs can 
cross the placenta, and, if given to patients in the child bearing age, may lead to serious 
teratologic sequelae. In addition, local and systemic immunological reactions could 
develop including local swelling and discharge (Dohin et al., 2009). Also, ectopic 
ossification could develop. In addition, the effects of BMPs on the growth plate remain 
unknown. Due to all these concerns, the use of BMPs is contraindicated in children and 
skeletally immature patients, thus precluding their use in a large population of patients 
that may benefit from BMPs.  
Two compelling questions then arise: first, how can we decrease these large doses of 
exogenous BMPs without altering their efficiency? Second, as an alternative, would 
manipulating the endogenous BMP pathway in DO by decreasing BMP antagonist 
expression increase the bioavailability of endogenous BMPs and enhance osteogenesis 
(without having to apply exogenous BMPs). We believe that a local sustained and prolonged 
release of low doses of rhBMPs would address the first question. To provide a sustained and 
prolonged release of BMPs, several options are currently being investigated: gene therapy, 
cell therapy, multiple repeated injections of rhBMPs or cytokine therapy. Gene therapy is 
still in the experimental stages of research (Long et al., 2011). Multiple repeated injections of 
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rhBMPs are not an option from a practical point of view. Cell therapy is a viable option, as 
was previously mentioned. However, in order to be effective, bone marrow mesenchymal 
stem cells have to be cultured before local application. Cytokine therapy is feasible 
provided, there is a delivery system that would ensure a sustained and prolonged delivery 
of adequate protein concentrations to the desired site (Haidar et al., 2009b; Haidar et al., 
2010b; Schmidmaier et al., 2008). 
14. Delivery systems for BMPs and other growth factors 
There is no question that the efficacy of BMPs in enhancing bone formation is dependent on 
its mode of delivery (Boerckel et al., 2011; La et al., 2010). In the absence of a suitable 
delivery system, huge doses of BMPs have to be used in order to overcome the rapid 
clearance and the very short life of BMPs. In order to be able to use low doses of BMPs that 
would be equally effective as a single large dose, an adequate delivery system that would 
allow the slow and controlled release of adequate concentrations (in low doses) of BMPs 
over the desired period of time becomes necessary. Probably, there is no single delivery 
system that would be suitable for all conditions. Rather, different delivery systems will be 
required for different pathologies (for example an injectable system may be required for 
some cases, while in others a locally applied one at the time of surgery would be indicated).  
Furthermore, as BMP2 and BMP7 have different temporal and spatial expression as well as 
different modes of action and different cellular targets, the use of a delivery system that 
would allow the sequential delivery of these two factors may present a huge step towards 
improving bone formation and a huge advantage over the use of a single factor.  
The literature is abundant on studies describing various delivery systems for BMPs and 
other growth factors, including various biomaterials, scaffolds, gene delivery and numerous 
tissue engineering techniques. Recently, the use of nanoparticles as a delivery system has 
gained popularity (Facca et al., 2011; Yilgor et al., 2010).  
14.1 Nanoparticles as delivery system  
Besides the known advantages including the size, long shelf life and ability to entrap more 
drugs (Gref et al., 1994), nano-sized systems reside longer in circulation, therefore greatly 
extend the biological activity when compared to microparticles (Desai et al., 1996). The 
literature provides evidence that particles (<500 nm) cross membranes of epithelial cells 
through endocytosis while larger particles (>5 mm) are taken up via the lymphatic system 
(Dong and Feng, 2004; Zhang and Feng, 2006).  
15. Ongoing research in our laboratory 
Our current research is focused on the use of BMPs in DO, specifically in two areas: first, the 
development of a delivery system for BMPs that would allow sustained and prolonged 
delivery of low doses of exogenous BMPs, with the same osteogenic effect of a single large 
dose, and second, to investigate if suppression of BMP antagonists could up-regulate the 
biological activity of endogenous BMPs so as to decrease or avoid the use the use of 
exogenous BMPs.  
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15.1 Development of a delivery system for BMPs 
Over the last 5 years, we have been working on the development of a unique hybrid core-
shell nanoparticle layer-by-layer (chitosan-alginate) delivery system. The core is 
composed of charged large unilamellar liposomes (LUVs) and the shell is constructed 
through the layer-by-layer (L-b-L) self-assembly of alternating layers of sodium alginate 
and chitosan. Alginates are water-soluble linear un-branched anionic polymers (marine 
sources, algae). Chitosan is a linear cationic polysaccharide (derived by the N-
deacetylation of chitin, a product found in the shells of crustaceans). It is a biocompatible, 
non-immunogenic, and biodegradable polymer with bioadhesive, wound healing, 
antimicrobial and even osteogenic properties; making it a favorable option for biomedical 
applications. Both, alginate and chitosan have been extensively studied for drug delivery 
in different forms, such as microcapsules, beads or even wound dressing membranes 
(Haidar et al., 2010b).  
In our laboratory, we have successfully completed all the in vitro characterization, 
formulation (Figure 11) and release kinetics studies (Haidar et al., 2008; Haidar et al., 2010a) 
of our NP system. Then, we showed the capability of the novel core-shell NPs to efficiently 
encapsulate and release a range of concentrations of rhBMP7 up to 45 days (Haidar et al., 
2009a) (Figure 12). In order to better understand the fate of the NPs and their targeted 
delivery, we have developed an imaging tool using quantum dots (QDs) and reported on 
the development of biocompatible chitosan-QD nanoparticles (Sandros et al., 2007). We then 
completed a toxicology study in rats, where we determined that our delivery system was 
safe and biocompatible (Haidar et al., 2010a). We then showed that a single injection of NPs 
loaded with low doses of rhBMP7 administered early in the distraction phase accelerated 
osteogenesis (Haidar et al., 2010b) and that some nanoparticles were detected in the 
distracted gap (Figure 13). 
Ongoing research in our laboratory is focused now on the optimization of the timing and 
dosage of the nanoparticle–BMP injections.  
 
 
 
Fig. 11. Layer-by-Layer self-assembly of Alginate (AL) and Chitosan (CH) on Liposomes (L) 
up to six layers are shown. Reprint with kind permission from Springer Science+Business 
Media B.V; Biotechnol Lett. 2009 Dec;31(12):1817-24. Delivery of recombinant bone morphogenetic 
proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Haidar ZS, 
Hamdy RC, Tabrizian M. 
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Fig. 12. Cumulative rhBMP7 release kinetic profile for uncoated liposomes (L), 3 bi-layered 
[L(AL-CH)3 or NPs3] and 5 bi-layered [L9AL-CH)5 or NPs5] core-shell NPs over an 
extended period of 45 days, in vitro. Controlled initial burst and rhBMP7 release from NPs is 
evident. Reprint with permission from J Biomed Mater Res A. 2009 Dec;91(3):919-28. 
 
Fig. 13. Histological images (Goldner-Trichrome stain) of the distracted gap of a rabbit 
model of DO that received a single injection of NPs with 0.5 µg of rhBMP7 two weeks post-
surgery, showing the persistence of NPs as indicated by the arrows. Animals were sacrificed 
five weeks after surgery (Data not published). 
16. Suppression of BMP antagonists 
As stated previously, the use of exogenous BMPs to enhance bone repair suffers from 
several drawbacks. Instead of administering exogenous BMPs to speed to up the 
regeneration process, an alternative strategy envisioned would be to inhibit BMP 
antagonists. This would allow increased levels of biologically active endogenous BMPs, 
which would in turn speed up the osteogenesis repair process. Attenuating BMP antagonist 
expression might also help to reduce the effective dose of exogenously applied BMP. This 
raises the question: do BMP antagonists play a role in fracture healing and new bone 
formation in DO? 
BMP antagonists have been identified as a broad class of molecules, (Figure 14), which control 
BMP activity through a negative feedback mechanism. Some BMP antagonists, such as Noggin 
and Chordin, interact directly with BMP ligands (mostly BMP2, 4, 6 and 7) to restrict their 
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biological activities extracellularly. Once bound to BMP antagonists, BMPs are prevented from 
interacting with their cognate membrane receptors and inducing intracellular signaling. BMP 
antagonists may also act at the membrane level (such as Bambi) or intracellularly (Smad 6 and 
7) (Cao and Chen, 2005; Gazzerro and Canalis, 2006; Rosen, 2006).  
 
Fig. 14. BMP Signaling and BMP Antagonists. 
Many in vitro studies have been conducted to investigate the role of BMP antagonists on 
osteoblast function and various aspects of osteogenesis and chondrogenesis. Noggin and 
Chordin have been particularly well studied in this context. Exogenous addition of Noggin 
or Chordin to osteoblast cell culture models results in the inhibition of expression for bone-
specific genes, alkaline phosphatase, osteocalcin and bone sialoprotein, with a concomitant 
decrease in mineralization potential (Tsialogiannis et al., 2009). 
Using transgenic and knockout animal models, many studies have revealed the crucial roles 
played by BMP antagonists in bone formation and repair. Over-expression of BMP 
antagonists has been shown to have detrimental effects on various bone parameters (Wu et 
al., 2003). In contrast, suppression of BMP antagonists using RNA interference caused 
increased osteogenic differentiation of cultured pre-osteoblastic cells, stromal cells and 
myoblastic cells (Kwong et al., 2008; Takayama et al., 2009). These findings strongly suggest 
that Noggin suppression via RNA interference stimulates bone formation in a mouse model 
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and may potentiate the effects of endogenous BMPs. Furthermore, as Noggin binds to 
several BMPs (BMP2, 4, 6 and 7), reducing Noggin expression may lead to increased 
availability of several, and not one BMP, thus reconstituting the normal biological 
environment, as compared to the exogenous application of BMPs, where only a single BMP, 
- either BMP2 or BMP7 can be locally applied.  
Numerous reports have emphasized the role BMP antagonists may play in fracture healing 
and the potential acceleration of new bone formation by inhibiting the inhibitors 
(Tsialogiannis et al., 2009). The expression of various BMP antagonists has been reported in 
human specimen of fracture healing and cases of non-unions (Kloen et al., 2002). However, 
there have been very few studies in humans, analysing the effects of blocking BMP 
antagonists on fracture healing (Lissenberg-Thunnissen et al., 2011).  
In the context of DO, we have previously shown in a mouse model of DO, that BMP 
antagonists, including BMP3, Noggin, Chordin and Inhibin showed significant increases in 
expression during the distraction process (Haque et al., 2008). 
 
Fig. 15. Immunohistochemical staining of regenerate bone in the distracted gap in a rabbit 
model of DO, five weeks after osteotomy of the tibia and distraction of 2.0 cms, showing 
intense staining for BMP antagonists Noggin and Chordin in cartilage-like cells.  
Based on these results, and a review of other reports in the literature, it would seem logical 
to hypothesize that these antagonists would be ideal candidates for therapeutic 
manipulation; blocking or inhibiting these antagonists, would in turn lead to up-regulation 
of BMPs and hence increased osteogenesis. The question then arises: which BMP antagonists 
to block and how to block them?  
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16.1 Methods to block BMP antagonists  
These include naturally occurring substances, such as Heparan sulphate, monoclonal 
antibodies, and small interfering RNAs. In our laboratory, we first investigated if locally 
applied heparin sulphate in a mouse model of DO would enhance bone formation. Our 
results did not show any benefit with the use of heparin sulphate (results submitted for 
publication). We then decided to attempt inhibit BMP antagonists with the use of RNA 
technology.  
16.1.1 RNA interference 
As a method to block BMP antagonists, the use of RNA interference techniques is of 
particular interest. RNA interference is a powerful new strategy that has been broadly 
utilized in recent years to elucidate gene function (Pushparaj et al., 2008). It consists of 
delivering gene-specific double stranded RNA into cells that eventually causes silencing 
(knockdown) of the expression of a target gene. The mechanism leading to mRNA 
degradation involves a complex series of steps mediated by the host cell post-transcriptional 
machinery (Rana, 2007). Although this technology is easily applicable in vitro, directly by 
transfecting cells with synthetic double stranded small interfering RNA (siRNA), it requires 
a different delivery system for it to be used in vivo. Viral-mediated gene delivery of small 
hairpin RNA (shRNA) is one of the methods of choice to achieve gene silencing in vivo. 
Lentiviruses represent a very flexible tool to modulate sustained gene expression both in 
vitro and in vivo. Lentiviral vectors are a method of choice because they: 1- infect both 
dividing and nondividing cells, 2- are less immunogenic because they are not encapsulated, 
3- have a wide tropism, 4- can be concentrated to high titers, and 5-incorporate into the host 
genome (Kootstra and Verma, 2003). Lentiviruses have been used and showed that they can 
infect osteoblasts with high efficiency in vitro. When directly applied in vivo into surgically 
created lesions of the mandible and tibia, lentiviruses were found to infect most cell types 
present in bone, especially in the regenerating chondrocytic callus of the tibia (Wazen et al., 
2006). A recent study showed success with lentiviral vectors as delivery system for shRNA-
mediated RNA interference in MC3T3 cells (Moffatt et al., 2008). 
Ongoing research in our laboratory aims at investigating the effects of blocking the BMP 
antagonists Noggin and Chordin using siRNA (small interfering RNA). We have chosen to 
focus our attention on Noggin and Chordin mainly because shRNA sequences against 
Noggin and Chordin have been identified previously to repress their expression with 
efficiencies greater than 80%. Furthermore, previous studies using knockout and transgenic 
mice revealed that Noggin suppression via RNA interference stimulates bone formation in a 
mouse model and may potentiate the effects of endogenous BMPs.As a first step and as 
proof of concept, we are using lentivirus to deliver siRNA to our mouse model of DO, as 
this delivery vehicle has been shown to have high transfection rate. Future research will aim 
at using our nanoparticle system for the delivery of siRNA in the context of DO.  
17. Conclusion and future perspectives in distraction osteogenesis research 
DO is a fascinating technique,  that has become a standard method for bone regeneration 
used worldwide for the treatment of numerous orthopaedic conditions associated with bone 
loss, deficiencies and poor bone formation.  The clinical importance of DO also extends to 
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the fields of craniofacial surgery and dentistry, where it has revolutionized the treatment of 
numerous previously untreatable pathologies.  
DO is not only of interest to clinicians, but is equally attractive to many scientists and 
researchers in various specialties including developmental and molecular biologists, 
chemists, protein scientists as well biomedical and tissue engineers.  
Opportunities for future research in DO are immense and include not only efforts aiming at 
enhancing bone formation but also the development of new devices for distracting bones, 
both internal and external, and novel methods to assess the quality and quantity of newly 
formed bone.   
In this chapter, various methods used to accelerate bone formation in DO were reviewed 
and the use of BMPs was specifically addressed. BMPs are probably the most potent 
osteogenic factors known to date, however, the huge doses that need to be used in humans 
may pose serious problems and adverse effects that limit their widespread use. How to 
improve the efficacy of BMPs in order to optimize their clinical use is the challenge that we, 
scientists and clinicians, are facing. Can we meet this challenge? Much more work needs to 
be done in that respect. Only two avenues, as pertained to our research program were 
discussed here: the development of an adequate delivery system and methods to inhibit the 
BMP antagonists. However, there are many more methods to increase the efficacy of BMPs 
that have been recently reported. BMP2 and BMP7 are the two most extensively studied 
BMPs, however, less known BMPs such as BMP6 and BMP9 may possess similar or even 
greater osteogenic properties than BMP2 and 7 and more experiments are needed in that 
area. Wnt signaling is emerging as a new and powerful osteogenic pathway that needs to be 
investigated, specifically in the context of DO. More experiments need to be performed in 
order to assess if the combined local application of growth factors BMP2 and BMP7 or BMP 
and TGFB may be more effective than the use of a single growth factor. The sequential 
application of BMP2 and BMP7 via a suitable delivery system is a very attractive concept 
that needs to be further analyzed in order to determine its clinical efficacy.  
There is no doubt that improving the technique of DO will have a huge impact medically, 
on the quality of life of patients and financially, on patients, their families and the health 
care system. Not only patients undergoing DO will benefit from advances in that field, but 
also patients with delayed fracture healing, non-unions and possibly also in patients with 
poor bony conditions, such as osteoporosis.  
More than half a century after the Magician of Kurgan, Ilizarov, unraveled the biological 
principles of DO, many questions still remain to be answered.  
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